Clinical trial
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for…
NCT00004645 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Unknown status
Key facts
| NCT number | NCT00004645 |
|---|---|
| Title | Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Collaborators | Mayo Clinic |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Disseminated Encephalomyelitis, Devic's Syndrome, Marburg's Variant of Multiple Sclerosis, Balo's Concentric Sclerosis, Acute Transverse Myelitis |
| Intervention type | Procedure |
| Interventions | Plasma exchange |
| Enrollment | 22 |
| Start date | Jan 1, 1995 |
| First posted | Feb 25, 2000 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: